SCHEMBL19106512

SCHEMBL19106512

Clc1nc(-c2cccc3ccccc23)c2sc3c4ccccc4c4ccccc4c3c2n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 1/20 0.33
▸ ALDH1A1 P00352 5/20 0.33
▸ HPGD P15428 4/20 0.33
▸ HSD17B10 Q99714 4/20 0.33
▸ CYP1A2 P05177 3/20 0.33
▸ THRB P10828 1/20 0.33
▸ RIPK2 O43353 1/20 0.32
▸ PRKD3 O94806 1/20 0.32
▸ ABL1 P00519 1/20 0.32
▸ FYN P06241 1/20 0.32
▸ SRC P12931 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ CSK P41240 1/20 0.32
▸ MAPK8 P45983 1/20 0.32
▸ CSNK1D P48730 1/20 0.32
▸ PRKCE Q02156 1/20 0.32
▸ PRKD1 Q15139 1/20 0.32
▸ PRKD2 Q9BZL6 1/20 0.32
▸ CAMK2A Q9UQM7 1/20 0.32
▸ RORC P51449 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17305859 0.82 ALDH1A1 (0.45) ALDH1A1HPGDCYP1A2MAPTSMN1; SMN2
SCHEMBL17297448 0.81 LIMK1 (0.37) TGFBR1ALDH1A1HPGDCYP1A2BCHE
SCHEMBL18132500 0.80 ALDH1A1 (0.38) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL18553237 0.79 RORB (0.40) ALDH1A1HPGDRORBMAPTSMN1; SMN2
SCHEMBL18853646 0.78 ALDH1A1 (0.31) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL18853039 0.78 ALDH1A1 (0.36) ALDH1A1HPGDHSD17B10RORBBCHE
SCHEMBL18853034 0.78 ALDH1A1 (0.36) ALDH1A1HPGDHSD17B10RORBBCHE
SCHEMBL18852937 0.77 ALDH1A1 (0.35) ALDH1A1HPGDHSD17B10RORBBCHE
SCHEMBL18853177 0.77 ALDH1A1 (0.35) ALDH1A1HPGDHSD17B10RORBBCHE
SCHEMBL17305860 0.76 ALOX5 (0.37) MAPTCYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 TGFBR1 4724/4885ALDH1A1 1024/4885HPGD 3291/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 TGFBR1 4724/4885ALDH1A1 1024/4885HPGD 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback